首页> 外文期刊>The Journal of heart valve disease >The bovine jugular vein: a totally integrated valved conduit to repair the right ventricular outflow.
【24h】

The bovine jugular vein: a totally integrated valved conduit to repair the right ventricular outflow.

机译:牛颈静脉:完全集成的带阀导管,可修复右心室流出。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND AND AIMS OF THE STUDY: Current techniques to correct valvular anomalies of the right ventricular outflow tract (RVOT) include repair and replacement of the pulmonary valve. However, the performance of currently used conduits has been less than ideal because of unfavorable hemodynamics and mid- to long-term complications. An early experience with a totally integrated Contegra valved conduit derived from a bovine jugular vein is reported; this conduit has the advantage that there is no discontinuity between its lumen and the valve it incorporates. METHODS: Between October 1999 and October 2001, a total of 22 Contegra valved conduits (12-22 mm) was implanted in 21 children aged <5 years, and in one patient aged 21 years. Diagnosis included tetralogy of Fallot (n = 13), pulmonary atresia (n = 3), double outlet right ventricle with pulmonary stenosis (PS) (n = 3), transposition of the great arteries, ventricular septal defect and PS (n = 2) and truncus arteriosus (n = 1). In 15 of these patients, distal and proximal anastomoses were performed on the beating heart. RESULTS: There was no mortality and no valved-conduit-related early morbidity. Intraoperative invasive assessment demonstrated excellent hemodynamic characteristics: mean peak pressure increase was 8.5+/-6.3 mmHg (varying between 4 mmHg in the 20-mm conduit and 18 mmHg in the 14-mm conduit). These values were confirmed by pre-discharge transthoracic pulsed-wave Doppler echocardiography. Because of endocarditis, one conduit was explanted after 11 months and replaced with a pulmonary homograft. Two patients required reintervention. CONCLUSION: The Contegra valved conduit is an excellent immediate substitute in the treatment of RVOT lesion when a pulmonary valve has to be inserted. Both systolic and diastolic valve functions are promising. Further data are required to confirm the favorable hemodynamics, as well as the durability and efficacy of this conduit in the long term.
机译:研究背景和目的:纠正右心室流出道(RVOT)瓣膜异常的当前技术包括修复和更换肺动脉瓣。但是,由于不利的血液动力学和中长期并发症,目前使用的导管的性能一直不理想。据报道,从牛颈静脉引出的全集成阀瓣导管的早期经验已经报道。该导管的优点是其内腔与内含的阀之间没有间断。方法:在1999年10月至2001年10月之间,共向21名5岁以下的儿童和1名21岁的患者植入了22条Contegra带瓣导管(12-22 mm)。诊断包括法洛四联症(n = 13),肺动脉闭锁(n = 3),右心室双出口伴肺动脉狭窄(PS)(n = 3),大动脉移位,室间隔缺损和PS(n = 2) )和动脉干(n = 1)。在其中的15例患者中,对跳动的心脏进行了远端和近端吻合。结果:没有死亡率,也没有瓣膜导管相关的早期发病率。术中侵入性评估显示出出色的血液动力学特征:平均峰值压力升高为8.5 +/- 6.3 mmHg(20 mm导管中的4 mmHg和14 mm导管中的18 mmHg之间变化)。放电前经胸脉冲多普勒超声心动图证实了这些值。由于心内膜炎,在11个月后移植了一根导管,并用肺同种异体移植代替。两名患者需要再次干预。结论:当需要插入肺动脉瓣时,Contegra瓣膜导管是治疗RVOT病变的极佳即时替代品。收缩阀和舒张阀的功能都有希望。需要进一步的数据来确认有利的血液动力学,以及长期来看该导管的耐用性和有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号